Dube Michael P (CIK 2019493) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Sell NTLA (2,641 shares), Buy NTLA (17,250 shares), Sell NTLA (2,989 shares), Sell NTLA (1,871 shares), Sell NTLA (2,503 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Sell | 2,641 | $44,316 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Buy | 17,250 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Sell | 2,989 | $27,529 |
| 2025-10-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Sell | 1,871 | $32,518 |
| 2025-07-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Sell | 2,503 | $24,905 |
| 2025-03-04 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | Buy | 14,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06